Abstract
Neonatal lupus is an uncommon condition associated with maternal anti-Ro autoantibodies. Findings may include cutaneous lupus lesions, third-degree heart block, cardiomyopathy, hepatobiliary disease, and/or thrombocytopenia or other hematologic cytopenias. It is common for only one organ to be affected, but any combination of organ involvement may occur. Recent studies have raised the possibility that the central nervous system may also be affected, but if it is, it is generally apparently asymptomatic. The most common severe manifestation of neonatal lupus is third-degree heart block, which usually begins during the second trimester of gestation. Attempts have been made to prevent the development of heart block, most often by treating the mother with systemic corticosteroids during pregnancy. There is not yet consensus as to the value of intervention during pregnancy. The neonatal lupus disease process is transient, although third-degree heart block, once established, is permanent. Cutaneous lesions tend to resolve completely and affected individuals tend to be healthy later in childhood. There does appear to be an increased risk for children who have had neonatal lupus to develop autoimmune diseases later in childhood or adulthood. The magnitude of that risk is uncertain. Mothers, who are often asymptomatic at the time of delivery of a baby with neonatal lupus, tend eventually to develop signs and symptoms of autoimmune disease.
Similar content being viewed by others
References
Blanford AT, Murphy BE (1977) In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta. Am J Obstet Gynecol 127:264–267 22
Boros CA, Spence D, Blaser S, Silverman ED (2007) Hydrocephalus and macrocephaly: new manifestations of neonatal lupus erythematosus. Arthritis Rheum 57:261–266. doi:10.1002/art.22543
Brucato A, Doria A, Frassi M, Castellino G, Franceschini F, Faden D et al (2002) Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus 11:716–721. doi:10.1191/0961203302lu252oa
Buyon JP, Clancy RM (2005) Neonatal lupus: basic research and clinical perspectives. Rheum Dis Clin North Am 31:299–313. doi:10.1016/j.rdc.2005.01.010 vii
Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M et al (1998) Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 31:1658–1666. doi:10.1016/S0735-1097(98)00161-2
David-Bajar KM, Bennion SD, DeSpain JD, Golitz LE, Lee LA (1992) Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus. J Invest Dermatol 99:251–257. doi:10.1111/1523-1747.ep12616582
Franco HL, Weston WL, Peebles C, Forstot SL, Phanuphak P (1981) Autoantibodies directed against sicca syndrome antigens in the neonatal lupus syndrome. J Am Acad Dermatol 4:67–72
Friedman DM, Kim MY, Copel JA, Davis C, Phoon CK, Glickstein JS et al (2008) Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR interval and dexamethasone evaluation (PRIDE) prospective study. Circulation 117:485–493. doi:10.1161/CIRCULATIONAHA.107.707661
Friedman DM, Rupel A, Buyon JP (2007) Epidemiology, etiology, detection, and treatment of autoantibody-associated congenital heart block in neonatal lupus. Curr Rheumatol Rep 9:101–108. doi:10.1007/s11926-007-0003-4
Julkunen H, Kaaja R, Wallgren E, Teramo K (1993) Isolated congenital heart block: fetal and infant outcome and familial incidence of heart block. Obstet Gynecol 82:11–16
Julkunen H, Kurki P, Kaaja R, Heikkila R, Immonen I, Chan EK et al (1993) Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La. Arthritis Rheum 36:1588–1598. doi:10.1002/art.1780361114
Kephart DC, Hood AF, Provost TT (1981) Neonatal lupus erythematosus: new serologic findings. J Invest Dermatol 77:331–333. doi:10.1111/1523-1747.ep12482531
Lee LA (2004) Neonatal lupus: clinical features and management. Paediatr Drugs 6:71–78. doi:10.2165/00148581-200406020-00001
Lee LA (2004) Neonatal lupus erythematosus: clinical findings and pathogenesis. J Investig Dermatol Symp Proc 9:52–56. doi:10.1111/j.1087-0024.2004.00827.x
Lee LA (2005) Transient autoimmunity related to maternal autoantibodies: neonatal lupus. Autoimmun Rev 4:207–213. doi:10.1016/j.autrev.2004.11.003
Lee LA, Frank MB, McCubbin VR, Reichlin M (1994) The autoantibodies of neonatal lupus erythematosus. J Invest Dermatol 102:963–966. doi:10.1111/1523-1747.ep12384148
Lee LA, Gaither KK, Coulter SN, Norris DA, Harley JB (1989) Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice. J Clin Invest 83:1556–1562. doi:10.1172/JCI114052
Lee LA, Sokol RJ, Buyon JP (2002) Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry. Pediatrics 109:E11. doi:10.1542/peds.109.1.e11
Martin V, Lee LA, Askanase AD, Katholi M, Buyon JP (2002) Long-term followup of children with neonatal lupus and their unaffected siblings. Arthritis Rheum 46:2377–2383. doi:10.1002/art.10638
McCuistion CH, Schoch EP Jr (1983) Possible discoid lupus erythematosus in newborn infant: report of a case with subsequent development of acute systemic lupus erythematosus in mother. Arch Dermatol 119:615–618. doi:10.1001/archderm.119.7.615
McCune AB, Weston WL, Lee LA (1987) Maternal and fetal outcome in neonatal lupus erythematosus. Ann Intern Med 106:518–523
Neiman AR, Lee LA, Weston WL, Buyon JP (2000) Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J Pediatr 137:674–680. doi:10.1067/mpd.2000.109108
Prendiville JS, Cabral DA, Poskitt KJ, Au S, Sargent MA (2003) Central nervous system involvement in neonatal lupus erythematosus. Pediatr Dermatol 20:60–67. doi:10.1046/j.1525-1470.2003.03014.x
Satter EK, High WA (2007) Non-bullous neutrophilic dermatosis within neonatal lupus erythematosus. J Cutan Pathol 34:958–960. doi:10.1111/j.1600-0560.2007.00758.x
Shinohara K, Miyagawa S, Fujita T, Aono T, Kidoguchi K (1999) Neonatal lupus erythematosus: results of maternal corticosteroid therapy. Obstet Gynecol 93:952–957. doi:10.1016/S0029-7844(99)00006-X
Taylor-Albert E, Reichlin M, Toews WH, Overholt ED, Lee LA (1997) Delayed dilated cardiomyopathy as a manifestation of neonatal lupus: case reports, autoantibody analysis, and management. Pediatrics 99:733–735. doi:10.1542/peds.99.5.733
Thornton CM, Eichenfield LF, Shinall EA, Siegfried E, Rabinowitz LG, Esterly NB et al (1995) Cutaneous telangiectases in neonatal lupus erythematosus. J Am Acad Dermatol 33:19–25. doi:10.1016/0190-9622(95)90004-7
Waltuck J, Buyon JP (1994) Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 120:544–551
Watson R, Kang JE, May M, Hudak M, Kickler T, Provost TT (1988) Thrombocytopenia in the neonatal lupus syndrome. Arch Dermatol 124:560–563. doi:10.1001/archderm.124.4.560
Weston WL, Morelli JG, Lee LA (1999) The clinical spectrum of anti-Ro-positive cutaneous neonatal lupus erythematosus. J Am Acad Dermatol 40:675–681. doi:10.1016/S0190-9622(99)70146-5
Conflict of interest statement
The author has no potential conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, L.A. The clinical spectrum of neonatal lupus. Arch Dermatol Res 301, 107–110 (2009). https://doi.org/10.1007/s00403-008-0896-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-008-0896-4